53 results
Page 2 of 3
424B5
w9r1ah0tmaozu4b
5 Mar 15
Prospectus supplement for primary offering
12:00am
424B2
ra9ium8ged
13 Jun 14
Prospectus for primary offering
12:00am
F-3
5491nda 0ml8wj
30 May 14
Shelf registration (foreign)
12:00am
424B5
dh5u bs2xo
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
ilb xs8hpem
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
3y1zes96
8 Aug 13
Prospectus supplement
12:00am
424B5
e3wmweo6kh6g
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
tzwlemc0xmgf4 094
17 May 13
Prospectus supplement for primary offering
12:00am
6-K
EX-10.1
qyjc2kgkq0exe5
17 May 13
BioLineRx Enters into “At-The-Market” Offering
12:00am
424B3
sdkqiwj 5lm
15 Oct 12
Prospectus supplement
12:00am
F-1
r4c1 1og9c4mu4t
2 Oct 12
Registration statement (foreign)
12:00am
6-K
wxvf3
4 Sep 12
Current report (foreign)
12:00am
424B3
lxyo2fe820j99mygp
2 Aug 12
Prospectus supplement
12:00am
POS AM
3hfyhromq4theq67437
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
989 6egyb6hxohrw5
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
6-K
EX-99.2
yeox7f rnicg8
16 Feb 12
Current Report, Foreign Issuer
12:00am
6-K
EX-1
n0qbg
13 Oct 11
Current report (foreign)
12:00am